bucladesine has been researched along with Vasculitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agah, A; Buras, J; Collard, CD; Reenstra, W; Stahl, GL | 1 |
Arita, H; Nakano, T; Ohara, O; Teraoka, H | 1 |
2 other study(ies) available for bucladesine and Vasculitis
Article | Year |
---|---|
Endothelial nuclear factor-kappaB translocation and vascular cell adhesion molecule-1 induction by complement: inhibition with anti-human C5 therapy or cGMP analogues.
Topics: Aminoquinolines; Antibodies, Monoclonal; Blotting, Western; Bucladesine; Cell Hypoxia; Cells, Cultured; Complement Membrane Attack Complex; Cyclic GMP; Dibutyryl Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Glutathione; Humans; Immunotherapy; Intercellular Adhesion Molecule-1; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroso Compounds; Oxygen; Penicillamine; S-Nitrosoglutathione; Umbilical Veins; Vasculitis; Vasodilation | 1999 |
Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Aorta, Thoracic; Bucladesine; Cells, Cultured; Colforsin; Cyclic AMP; Dactinomycin; Drug Synergism; Gene Expression; Interleukin-1; Lipopolysaccharides; Male; Muscle, Smooth, Vascular; Phospholipases; Phospholipases A; Phospholipases A2; Rats; Rats, Inbred Strains; RNA, Messenger; Tumor Necrosis Factor-alpha; Vasculitis | 1990 |